A specific antidote for dabigatran: functional and structural characterization.
Schiele F, van Ryn J, Canada K, Newsome C, Sepulveda E, Park J, Nar H, Litzenburger T.
Blood · journal article · DOI 10.1182/blood-2012-11-468207 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för dabigatran. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
21 träffarThe use of FEIBA® in the correction of coagulation abnormalities induced by dabigatran.
Khoo TL, Weatherburn C, Kershaw G, Reddel CJ, Curnow J, Dunkley S.
Int J Lab Hematol · journal article · DOI 10.1111/ijlh.12005Hemopericardium and cardiac tamponade associated with dabigatran use.
Dy EA, Shiltz DL.
Ann Pharmacother · journal article; case reports · DOI 10.1345/aph.1r112Dabigatran: rational dose individualisation and monitoring guidance is needed.
Duffull SB, Wright DF, Al-Sallami HS, Zufferey PJ, Faed JM.
N Z Med J · journal articleAn indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Mantha S, Ansell J.
Thromb Haemost · comparative study; review; journal article · DOI 10.1160/th12-02-0093Dabigatran: a primer for neurosurgeons.
Fugate JE, Rabinstein AA, McBane RD, Lanzino G.
World Neurosurg · research support, non-u.s. gov't; review; journal article · DOI 10.1016/j.wneu.2012.06.019Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.
Healey JS, Eikelboom J, Douketis J, Wallentin L, Oldgren J, Yang S, Themeles E, Heidbuchel H, Avezum A, Reilly P, Connolly SJ, Yusuf S, Ezekowitz M, RE-LY Investigators.
Circulation · comparative study; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1161/circulationaha.111.090464Hemorrhagic gastritis with dabigatran in a patient with renal insufficiency.
Fellows SE, Rosini JM, Curtis JA, Volz EG.
J Emerg Med · journal article; case reports · DOI 10.1016/j.jemermed.2012.02.042Dabigatran for stroke prevention in nonvalvular atrial fibrillation: answers to challenging "real-world" questions.
Ferreira J, Ferreira D, Viana-Baptista M, Bettencourt P, Cernadas R, Crespo F.
Thrombosis · review-article; journal article · DOI 10.1155/2012/867121[The monitoring of application of dabigatran as a remedy of prevention of thromboembolic complications after hip joint arthroplasty].
Momot AP, Grigor'ev EV, Tsyvkina LP, Panov MIu, Merkulov IV.
Klin Lab Diagn · journal article; english abstractDabigatran and dabigatran ethyl ester: potent inhibitors of ribosyldihydronicotinamide dehydrogenase (NQO2).
Michaelis S, Marais A, Schrey AK, Graebner OY, Schaudt C, Sefkow M, Kroll F, Dreger M, Glinski M, Koester H, Metternich R, Fischer JJ.
J Med Chem · journal article · DOI 10.1021/jm3001339Plasma-diluted thrombin time to measure dabigatran concentrations during dabigatran etexilate therapy.
Avecilla ST, Ferrell C, Chandler WL, Reyes M.
Am J Clin Pathol · journal article · DOI 10.1309/ajcpau7oqm0srpzqThromboembolic prophylaxis in orthopedic surgery using dabigatran: an oral direct thrombin inhibitor.
Garza R, Huo MH.
Expert Rev Cardiovasc Ther · review; journal article · DOI 10.1586/erc.12.15Anticoagulation therapy. Dabigatran and risk of myocardial infarction.
Eikelboom JW, Weitz JI.
Nat Rev Cardiol · comment; journal article · DOI 10.1038/nrcardio.2012.34Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran.
Stangier J, Feuring M.
Blood Coagul Fibrinolysis · research support, non-u.s. gov't; journal article · DOI 10.1097/mbc.0b013e32834f1b0cStroke prophylaxis with warfarin or dabigatran for patients with non-valvular atrial fibrillation-cost analysis.
Ali A, Bailey C, Abdelhafiz AH.
Age Ageing · comparative study; journal article · DOI 10.1093/ageing/afs017Determination of dabigatran in human plasma samples.
Harenberg J, Giese C, Marx S, Krämer R.
Semin Thromb Hemost · research support, non-u.s. gov't; review; journal article · DOI 10.1055/s-0031-1300947Dabigatran and atrial fibrillation: the alternative to warfarin for selected patients.
Författaruppgift saknas
Prescrire Int · comparative study; review; journal articleMyocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial.
Hohnloser SH, Oldgren J, Yang S, Wallentin L, Ezekowitz M, Reilly P, Eikelboom J, Brueckmann M, Yusuf S, Connolly SJ.
Circulation · randomized controlled trial; research support, u.s. gov't, non-p.h.s.; journal article · DOI 10.1161/circulationaha.111.055970[Dabigatran and emergency operation on a peritonitis patient].
Ilmakunnas M, Louhimo J, Lassila R.
Duodecim · review; journal article; english abstractClinical pharmacology basis of deriving dosing recommendations for dabigatran in patients with severe renal impairment.
Hariharan S, Madabushi R.
J Clin Pharmacol · controlled clinical trial; clinical trial, phase i; journal article · DOI 10.1177/0091270011415527